Ellen Q. Wang
Impact in
-
- Biosimilars and Bioanalytical Methods
-
- Dermatology and Skin Diseases
Papers in
-
- Biosimilars and Bioanalytical Methods 3
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Christie M. Ballantyne (1 shared paper)Kevin Sweeney (1 shared paper)Joel Neutel (1 shared paper)William Duggan (1 shared paper)David R. Plowchalk (1 shared paper)Harold Bays (1 shared paper)John Vincent (1 shared paper)Bimal Malhotra (3 shared papers)
- Journals
- Alzheimer s & Dementia (3 papers)The Journal of Clinical Pharmacology (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Ellen Q. Wang
17 papers receiving 395 citations
Peers
Comparison fields: 5 of 63
- Immunology 83
- Dermatology 32
- Rheumatology 53
- Urology 22
- Surgery 141
Countries citing papers authored by Ellen Q. Wang
This map shows the geographic impact of Ellen Q. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Q. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Q. Wang more than expected).
Fields of papers citing papers by Ellen Q. Wang
This network shows the impact of papers produced by Ellen Q. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Q. Wang. The network helps show where Ellen Q. Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Q. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 142 | |
| 2 | 2010 | 58 | |
| 3 | 2011 | 36 | |
| 4 | 2021 | 32 | |
| 5 | 2023 | 26 | |
| 6 | 2012 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2009 | 15 | |
| 9 | 2017 | 11 | |
| 10 | 2009 | 8 | |
| 11 | 2019 | 7 | |
| 12 | 2009 | 7 | |
| 13 | 2012 | 6 | |
| 14 | 2002 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2018 | 4 |
About Ellen Q. Wang
Ellen Q. Wang is a scholar working on Immunology, Molecular Biology, Pediatrics, Perinatology and Child Health, Physiology and Economics and Econometrics, having authored 17 papers that have together received 403 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (3 papers), Pharmaceutical Economics and Policy (3 papers), Dermatology and Skin Diseases (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers), Receptor Mechanisms and Signaling (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Immunology (83 citations), Dermatology (32 citations), Rheumatology (53 citations), Urology (22 citations) and Surgery (141 citations). Ellen Q. Wang has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Christie M. Ballantyne, Kevin Sweeney, Joel Neutel, William Duggan, David R. Plowchalk, Harold Bays, John Vincent, Bimal Malhotra, Martin E. Dowty and Lisy Wang. Their work appears in journals such as Alzheimer s & Dementia, The Journal of Clinical Pharmacology, Cancer Research, Clinical Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.